Medical/Pharmaceuticals
ETANA HAS SECURED B ROUND FINANCING
JAKARTA, Indonesia, Sept. 28, 2022 /PRNewswire/ -- PT Etana Biotechnologies Indonesia (Etana), an Indonesian biopharmaceutical company, has secured B round of financing led by Yunfeng Capital and followed by HighLight Capital. This round of financing will be mainly used for further strengthening ...
Ascletis Announces Dosing of the First Patient in the Phase IIb Expansion Cohort of ASC22 (Envafolimab) for Chronic Hepatitis B Functional Cure
-- After the pre-Phase III clinical trial meeting with Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) in June 2022, the pathway to the registration, including patient population, dose, treatment duration, etc. of ASC22 (Envafolimab) for functional cure of...
Chinese NMPA Approves Study of Telix Kidney Cancer Imaging Candidate
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the Chinese National Medical Products Administration (NMPA) Center for Drug Evaluation (CDE) has approved a pivotal Phase III registration study that will bridge ...
First Patient in Australia Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging Agent
MELBOURNE, Australia, Sept. 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the first commercial dose inAustralia of its prostate cancer imaging agent, Illuccix® (Kit for Preparation of Ga-68 Glu-urea-Lys(ahx)-hbed-CC Injection), also known as...
Metabolon Expands Data Access Strategy to Include Health for Life in Singapore (HELIOS) Study
Metabolon to collaborate with NTU Singapore's medical school to identify biomarkers for the prevention, diagnosis, and treatment of disease. MORRISVILLE, N.C., Sept. 27, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of res...
TargEDys and Inoliva announce they have entered a distribution partnership to bring Satylia® to Turkey
LONGJUMEAU, France, Sept. 27, 2022 /PRNewswire/ -- TargEDys and Inoliva, an affiliate ofAbdi Ibrahim, have signed an exclusive marketing and distribution agreement to bring Satylia, a food supplement based on the next-generation probioticHafnia alvei HA4597, to the Turkish market. Satylia, al...
Sciwind Biosciences and SynerK Enter into Research Partnership to Discover and Develop Novel siRNA Therapeutics
The partnership combines Sciwind's expertise in disease biology and clinical development capabilities with SynerK's proprietary conjugate-based siRNA delivery technology and expertise in developing RNAi therapeutics SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 27, 2022 /PRNewswire/ -- Sciwin...
Luye Pharma Enters Local Seroquel® Distribution and Marketing Partnership with ICI Pakistan Limited
"We Care About Mental Health" awareness set to increase across APAC * Luye Pharma has granted ICI Pakistan Limited exclusive distribution and marketing rights for Seroquel® in Pakistan. * As part of the "We Care About Mental Health" initiative, the two companies have pledged to make joint ef...
First Patient Enrolled in ProstACT TARGET Study
MELBOURNE, Australia, Sept. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) and GenesisCare, the largest provider of integrated cancer care inAustralia, today announce that a first patient has been enrolled in the Phase II ProstACT TARGET study of Telix's pro...
BEYOND Expo | Nobel laureate Roger Kornberg on new solutions to health challenges
BEIJING, Sept. 27, 2022 /PRNewswire/ -- Society has long faced public health challenges in developing better drugs at a lower cost, preparing for future pandemics, and preventing diseases. During the opening day of BEYOND Expo 2022, Dr.Roger Kornberg, the 2006 Nobel Prize winner in Chemistry, sha...
In commemoration of World Pharmacists Day 2022, P&G Health lauds pharmacists and the role they play in providing whole-of-body healthcare to patients
* P&G Health commemorated World Pharmacists Day 2022 across the Asia Pacific, Middle East, and Africa region through a host of activities * This includes the first ever P&G Health Middle-East Whole-Body Health Symposium over 2 days in which 12,813 participants from 111 countries took part SIN...
Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression
* Data demonstrated that a single administration of BRII-296 at 600 mg delivered a favorable pharmacokinetic profile and is safe and well-tolerated in healthy subjects * Findings suggest BRII-296 has potential to provide a safe and effective, one-time injectable treatment option to people wit...
MGI Launches Ultra High Speed DNBSEQ-G99 Gene Sequencer* with Mid to Low Range Throughput
SHENZHEN, China, Sept. 26, 2022 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI) on 9 September officially launched DNBSEQ-G99*, the latest model of the gene sequencer* with mid to low range throughput. As one of the sequencers* with the fastest speed among those with the same throughput in the world...
Nippon Express (China) Participates in 11th Global Pharmaceutical Cold Chain Summit
TOKYO, Sept. 26, 2022 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., participated in the three-day 11th Global Pharmaceutical Cold Chain Summit hosted by the China Federation of Logistics & Purchasing and held inChongqi...
CellResearch Corporation (CRC) to present promising new stem cell products for the treatment of chronic diabetic foot ulcers at the world's premier diabetic foot conference (DFCon) in Los Angeles
- CRC data on cord lining media for the treatment of diabetic foot ulcers has been accepted at the DFCon, with DrWong Keng Lin Francis, CRC's latest KOL, presenting his findings to world leaders in the field of DFU. - Similarly, the results of Corlicyte™'s Phase 1 study on the treatment of chro...
Everest Medicines Receives Approval of Investigational New Drug Application from China NMPA for EVER001, a Novel BTK Inhibitor in Development for Treatment of Renal Diseases
Advancement highlights Everest's potential in providing first-in-class
therapies to global patients with glomerular disease
SHANGHAI, Sept. 26, 2022 /PRNewswire/ -- Everest Medicines
AAHRPP Accredits Five More Research Organizations, Including First in Japan
WASHINGTON, Sept. 24, 2022 /PRNewswire/ -- The Association for the Accreditation of Human Research Protection Programs has accredited five more research organizations, including its first organization inJapan, two public research universities, a children's hospital and an acute-care hospital. At...
Mentice AB (publ) receives an order of USD 620,000 for simulation solutions and development services
GOTHENBURG, Sweden, Sept. 23, 2022 /PRNewswire/ -- Mentice AB (publ), Gothenburg , a world leader in simulation solutions for image-guided interventional therapies, announced today that a leading global healthcare technology company, has signed an agreement to acquire Mentice VIST® simulation solu...
Shandong Proton Center Celebrates Milestone in Delivering High-Quality Proton Treatment
BEIJING, Sept. 23, 2022 /PRNewswire/ -- On July 20, 2022, the Shandong Proton Center (SDPT) treated the first four participants enrolled in a clinical trial, marking a key milestone on the path to expanding access to advanced cancer care – including proton therapy – inChina. Proton therapy can b...
WINNERS OF THE 2023 BREAKTHROUGH PRIZES IN LIFE SCIENCES, MATHEMATICS AND FUNDAMENTAL PHYSICS ANNOUNCED
$15.75 Million in Prizes Awarded for Predicting Protein Structure with Deep Learning, Pioneering Field of Quantum Information, and Discoveries with Applications from Treating Neurodegenerative Disease to Optimizing Video Transmission Breakthrough Prize in Life Sciences Awarded to Clifford P. Bra...
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 328 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 321 media titles]
2024-05-15 12:00Innomix and World Castle Association Pioneer LBMR project at Zhangbi Fortress
[Picked up by 317 media titles]
2024-05-20 13:48Samsung Electronics Unveils Month-Long Celebration of Esports Events for Students in Southeast Asia
[Picked up by 313 media titles]
2024-05-21 08:00Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 308 media titles]
2024-05-16 15:00